Skip to main content
Erschienen in: Journal of Neurology 1/2015

01.01.2015 | Original Communication

Tissue microstructural changes in dementia with Lewy bodies revealed by quantitative MRI

verfasst von: Li Su, Andrew M. Blamire, Rosie Watson, Jiabao He, Benjamin Aribisala, John T. O’Brien

Erschienen in: Journal of Neurology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

We aimed to characterize dementia with Lewy bodies (DLB) by the quantitative MRI parameters of longitudinal relaxation time (qT1) and transverse relaxation time (qT2). These parameters reflect potential pathological changes in tissue microstructures, which may be detectable noninvasively in brain areas without evident atrophy, so may have potential value in revealing the early neuropathological changes in DLB. We conducted a cross-sectional study of subjects with DLB (N = 35) and similarly aged control participants (N = 35). All subjects underwent a detailed clinical and neuropsychological assessment and structural and quantitative 3T MRI. Quantitative MRI maps were obtained using relaxation time mapping methods. Statistical analysis was performed on gray matter qT1 and qT2 values. We found significant alterations of quantitative parameters in DLB compared to controls. In particular, qT1 decreases in bilateral temporal lobes, right parietal lobes, basal ganglia including left putamen, left caudate nucleus and left amygdala, and left hippocampus/parahippocampus; qT2 decreases in left putamen and increases in left precuneus. These regions showed only partial overlap with areas where grey matter loss was found, making atrophy an unlikely explanation for our results. Our findings support that DLB is predominantly associated with changes in posterior regions, such as visual association areas, and subcortical structures, and that qT1 and qT2 measurement can detect subtle changes not seen on structural volumetric imaging. Hence, quantitative MRI may compliment other imaging techniques in detecting early changes in DLB and in understanding neurobiological changes associated with the disorder.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872CrossRefPubMed McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872CrossRefPubMed
2.
Zurück zum Zitat Watson R, O’Brien JT, Barber R, Blamire AM (2012) Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. Int Psychogeriatr 24:532–543CrossRefPubMed Watson R, O’Brien JT, Barber R, Blamire AM (2012) Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. Int Psychogeriatr 24:532–543CrossRefPubMed
3.
Zurück zum Zitat Watson R, Blamire AM, Colloby SJ et al (2012) Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology 79:906–914PubMedCentralCrossRefPubMed Watson R, Blamire AM, Colloby SJ et al (2012) Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology 79:906–914PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Burton EJ et al (2002) Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. NeuroImage 17:618–630CrossRefPubMed Burton EJ et al (2002) Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. NeuroImage 17:618–630CrossRefPubMed
5.
Zurück zum Zitat Beyer MK, Larsen JP, Aarsland D (2007) Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 69:747–754CrossRefPubMed Beyer MK, Larsen JP, Aarsland D (2007) Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 69:747–754CrossRefPubMed
6.
7.
Zurück zum Zitat Lippa CF, Johnson R, Smith TW (1998) The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer’s disease. Ann Neurol 43:102–106CrossRefPubMed Lippa CF, Johnson R, Smith TW (1998) The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer’s disease. Ann Neurol 43:102–106CrossRefPubMed
8.
Zurück zum Zitat Burton EJ et al (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 132:195–203CrossRefPubMed Burton EJ et al (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 132:195–203CrossRefPubMed
9.
Zurück zum Zitat Lobotesis K, Fenwick JD, Phipps A et al (2001) Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56:643–649CrossRefPubMed Lobotesis K, Fenwick JD, Phipps A et al (2001) Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56:643–649CrossRefPubMed
10.
Zurück zum Zitat Minoshima S, Foster NL, Petrie EC et al (2002) Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. J Geriatr Psychiatry Neurol 15:200–209CrossRefPubMed Minoshima S, Foster NL, Petrie EC et al (2002) Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. J Geriatr Psychiatry Neurol 15:200–209CrossRefPubMed
11.
Zurück zum Zitat Hanyu H, Shimizu S, Hirao K et al (2006) Differentiation of dementia with Lewy bodies from Alzheimer’s disease using mini-mental state examination and brain perfusion SPECT. J Neurol Sci 250:97–102CrossRefPubMed Hanyu H, Shimizu S, Hirao K et al (2006) Differentiation of dementia with Lewy bodies from Alzheimer’s disease using mini-mental state examination and brain perfusion SPECT. J Neurol Sci 250:97–102CrossRefPubMed
12.
Zurück zum Zitat Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B et al (2010) Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease with dementia. Mov Disord 25:615–622CrossRefPubMed Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B et al (2010) Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease with dementia. Mov Disord 25:615–622CrossRefPubMed
13.
Zurück zum Zitat Piggott MA, Marshall EF, Thomas N et al (1999) Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases: rostrocaudal distribution. Brain 122(Pt 8):1449–1468CrossRefPubMed Piggott MA, Marshall EF, Thomas N et al (1999) Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases: rostrocaudal distribution. Brain 122(Pt 8):1449–1468CrossRefPubMed
14.
Zurück zum Zitat McKeith I, O’Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305–313CrossRefPubMed McKeith I, O’Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305–313CrossRefPubMed
15.
Zurück zum Zitat Cousins DA, Burton EJ, Burn D et al (2003) Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: an MRI study. Neurology 61:1191–1195CrossRefPubMed Cousins DA, Burton EJ, Burn D et al (2003) Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: an MRI study. Neurology 61:1191–1195CrossRefPubMed
16.
Zurück zum Zitat Tofts P (2003) Quantitative MRI of the brain: measuring changes caused by disease. Wiley, New YorkCrossRef Tofts P (2003) Quantitative MRI of the brain: measuring changes caused by disease. Wiley, New YorkCrossRef
17.
Zurück zum Zitat Draganski B, Ashburner J, Hutton C et al (2011) Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ). NeuroImage 55:1423–1434PubMedCentralCrossRefPubMed Draganski B, Ashburner J, Hutton C et al (2011) Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ). NeuroImage 55:1423–1434PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Spencer NG, Bridgesb LR, Elderfield K et al (2013) Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain. NeuroImage 76:108–115CrossRefPubMed Spencer NG, Bridgesb LR, Elderfield K et al (2013) Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain. NeuroImage 76:108–115CrossRefPubMed
19.
Zurück zum Zitat Folstein M, Folstein S, McHugh P (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein M, Folstein S, McHugh P (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
20.
Zurück zum Zitat Fahn S, R Elton, Members of the UPDRS Development Committee (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Health Care Information, Florham Park, pp 153–164 Fahn S, R Elton, Members of the UPDRS Development Committee (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Health Care Information, Florham Park, pp 153–164
21.
Zurück zum Zitat Cummings JL, Mega M, Gray K et al (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314CrossRefPubMed Cummings JL, Mega M, Gray K et al (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314CrossRefPubMed
22.
Zurück zum Zitat Bucks RS, Ashworth DL, Wilcock GK, Siegfried K (1996) Assessment of activities of daily living in dementia: development of the bristol activities of daily living scale. Age Ageing 25:113–120CrossRefPubMed Bucks RS, Ashworth DL, Wilcock GK, Siegfried K (1996) Assessment of activities of daily living in dementia: development of the bristol activities of daily living scale. Age Ageing 25:113–120CrossRefPubMed
23.
Zurück zum Zitat Clare S, Jezzard P (2001) Rapid T-1 mapping using multislice echo planar imaging. Magn Reson Med 45:630–634CrossRefPubMed Clare S, Jezzard P (2001) Rapid T-1 mapping using multislice echo planar imaging. Magn Reson Med 45:630–634CrossRefPubMed
24.
25.
26.
Zurück zum Zitat Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15:273–289CrossRefPubMed Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15:273–289CrossRefPubMed
27.
Zurück zum Zitat O’Brien JT, Colloby S, Fenwick J et al (2004) Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 61:919–925CrossRefPubMed O’Brien JT, Colloby S, Fenwick J et al (2004) Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 61:919–925CrossRefPubMed
28.
Zurück zum Zitat Klein JC, Eggers C, Kalbe E et al (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74:885–892CrossRefPubMed Klein JC, Eggers C, Kalbe E et al (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74:885–892CrossRefPubMed
29.
Zurück zum Zitat Edison P, Rowe CC, Rinne JO et al (2008) Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331–1338CrossRefPubMed Edison P, Rowe CC, Rinne JO et al (2008) Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331–1338CrossRefPubMed
30.
Zurück zum Zitat Shimada H, Hirano S, Shinotoh H et al (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73:273–278CrossRefPubMed Shimada H, Hirano S, Shinotoh H et al (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73:273–278CrossRefPubMed
31.
Zurück zum Zitat Kantarci K, Avula R, Senjem ML et al (2010) Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 74:1814–1821PubMedCentralCrossRefPubMed Kantarci K, Avula R, Senjem ML et al (2010) Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 74:1814–1821PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Bunzeck N, Eckart C, Singh-Curry V et al (2013) Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson’s disease. Parkinsonism Relat Disord 19(12):1136–1142PubMedCentralCrossRefPubMed Bunzeck N, Eckart C, Singh-Curry V et al (2013) Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson’s disease. Parkinsonism Relat Disord 19(12):1136–1142PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Gelman N, Ewing JR, Gorell JM et al (2001) Interregional variation of longitudinal relaxation rates in human brain at 3.0T: relation to estimated iron and water contents. Magn Reson Med 45:71–79CrossRefPubMed Gelman N, Ewing JR, Gorell JM et al (2001) Interregional variation of longitudinal relaxation rates in human brain at 3.0T: relation to estimated iron and water contents. Magn Reson Med 45:71–79CrossRefPubMed
35.
Zurück zum Zitat MacKay A, Whittall K, Adler J et al (1994) In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 31:673–677CrossRefPubMed MacKay A, Whittall K, Adler J et al (1994) In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 31:673–677CrossRefPubMed
36.
Zurück zum Zitat Lutti A, Dick F, Sereno MI et al (2014) Using high-resolution quantitative mapping of R1 as an index of cortical myelination. Neuroimage 93:176–188CrossRefPubMed Lutti A, Dick F, Sereno MI et al (2014) Using high-resolution quantitative mapping of R1 as an index of cortical myelination. Neuroimage 93:176–188CrossRefPubMed
37.
Zurück zum Zitat Fukunaga M, Li TQ, van Gelderen P et al (2010) Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci USA 107:3834–3839PubMedCentralCrossRefPubMed Fukunaga M, Li TQ, van Gelderen P et al (2010) Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci USA 107:3834–3839PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Gelman N, Ewing JR, Gorell JM et al (2001) Interregional variation of longitudinal relaxation rates in human brain at 3.0T: relation to estimated iron and water contents. Magn Reson Med 45:71–79CrossRefPubMed Gelman N, Ewing JR, Gorell JM et al (2001) Interregional variation of longitudinal relaxation rates in human brain at 3.0T: relation to estimated iron and water contents. Magn Reson Med 45:71–79CrossRefPubMed
39.
Zurück zum Zitat Aribisala BS, He J, Blamire AM (2011) Comparative study of standard space and real space analysis of quantitative MR brain data. J Magn Reson Imaging 33(6):1503–1509CrossRefPubMed Aribisala BS, He J, Blamire AM (2011) Comparative study of standard space and real space analysis of quantitative MR brain data. J Magn Reson Imaging 33(6):1503–1509CrossRefPubMed
Metadaten
Titel
Tissue microstructural changes in dementia with Lewy bodies revealed by quantitative MRI
verfasst von
Li Su
Andrew M. Blamire
Rosie Watson
Jiabao He
Benjamin Aribisala
John T. O’Brien
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 1/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7541-2

Weitere Artikel der Ausgabe 1/2015

Journal of Neurology 1/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.